Background: There are increasing concerns over adverse effects of prenatal phthalate exposure on the neurodevelopment of infants. 
Recent evidence suggests that environmental pollutants can be detrimental to the neuro cognitive development of children (Bellinger 2008) . Such evidence is especially strong in the case of lead, which has been shown to manifest detrimental effects on intelligence (Canfield et al. 2003) and increase hyper activity and impulsivity in children (Braun et al. 2006; Kim et al. 2010) . The exposure of children to phthalates has raised concerns, because these chemicals have been associated with developmental and reproductive toxic effects in laboratory animals (Borch et al. 2006; Gray et al. 2000; Ishido et al. 2004b) . Previous animal studies have reported that phthalates cause hyperactivity and impulsivity in rats; which appears similar to the clinical features of attention deficit hyperactivity dis order (ADHD), a condition most commonly identified in schoolaged children (Ishido et al. 2004b; Masuo et al. 2004) . A recent cross sectional survey reported associations between phthalate metabolites and intelligence scores and ADHD symptoms in schoolaged children ).
Phthalates-diesters of 1,2benzene dicarboxylic acid (phthalic acid)-are a group of synthetic chemicals with a wide spectrum of industrial and commercial uses, includ ing primary plasticizers for polyvinyl chlo ride and solvents in personal care products (Wormuth et al. 2006) . Phthalate plasticiz ers are slowly emitted into the surrounding environment (Wormuth et al. 2006) , consti tuting an indoor pollutant (Bornehag et al. 2005) . Phthalates can be ingested through food or inhaled through contaminated air or dust. Dermal contact with care products that contain phthalates and medical devices contaminated with phthalates are another possible source of exposure (HernandezDiaz et al. 2009 ). After entering the body, phtha lates undergo rapid metabolism to monoesters and can also be oxidized further to oxidative metabolites (Engel et al. 2010) .
Phthalates are suspected to interfere with the thyroid hormone system (Ghisari and BonefeldJorgensen 2009; Huang et al. 2007 ), a system vital to normal brain development in the fetus and infant (Berbel et al. 2010 ).
The maternal transmission of phthalates to offspring has been demonstrated; these com pounds have been found in the amniotic fluid and fetal circulation in humans (Huang et al. 2009; Wittassek et al. 2009 ). It has been estimated that infants may experience higher exposures to phthalates in relation to their body weight (Wormuth et al. 2006 ). All of these findings suggest that phthalates may cause disturbances in the normal develop mental trajectory of the fetal and infant brain (Tanida et al. 2009 ). Prenatal exposure to phthalates has been associated with poor birth outcomes (Wolff et al. 2008) , neurological outcomes in the neonate (Engel et al. 2009 ), behavioral problems (Engel et al. 2010) , reduced masculine play in boys (Swan et al. 2010) , and social impairment (Miodovnik et al. 2011) in childhood. However, the effects of prenatal phthalate exposure on neuro development at infants at 6 months have not been investigated.
In this study, we hypothesized that pre natal exposure to di(2ethylhexyl) phthalate (DEHP) and dibutyl phthalate (DBP) would be inversely associated with Mental and Psychomotor Developmental Indices (MDI and PDI, respectively), as measured by the Korean Bayley Scales of Infant Development, 2nd edition (BSIDII) at 6 months (Bayley 1993; Park and Cho 2006) .
Methods
Recruitment of participants. This study was part of the Mothers and Children's Environmental Health Study (MOCEH), an ongoing multicenter prospective cohort study of environmental factors contributing to the health of mothers and children. The study protocols, which were approved by the volume 119 | number 10 | October 2011 • Environmental Health Perspectives Institutional Review Boards of Ewha Womans University, Dankook University Hospital, and Ulsan University Hospital, are described in detail elsewhere (Kim BM et al. 2009 ). In brief, pregnant women in their first trimester were approached for recruitment at obstetric clinics located in Seoul (a metropolitan city with population of 10,464,051 and a popu lation density of 16,586/km 2 ), Cheonan (a mixture of rural and hightech industrial area with population of 570,107 and a population density of 895/km 2 ), and Ulsan (an indus trial area with population of 1,129,962 and a population density of 1,034/km 2 ). The inclu sion criteria were pregnant women who were age > 18 years and residence at the targeted study site at the time of enrollment. Eligible pregnant women visiting the obstetric clinics were invited to participate through posters on the walls of the clinic and by the examin ing obstetric doctors. All study participants provided written informed consent at enroll ment. From 2006 through 2009, 718 children (50.0% of enrolled children were followed at 6 months) were examined at 6 months of age.
MDI and PDI assessed at 6 months. The BSIDII produces indicators of infant neu rodevelopment from 0 to 3 years of age (Bayley 1993) . Each test produces developmental indi ces (composite scores that compare develop mental performance of a child with the norms taken from typically developing Korean chil dren of the same age), which are expressed as the MDI and the PDI (Park and Cho 2006) . The BSIDII was conducted in a quiet room by trained examiners for 30 to 45 min. Training on the BSIDII was coordinated by a special ist (interrater reliability: kappa value > 0.8) before the beginning of the evaluation of the infants. The intelligence of the mother was measured using the short form of the Korean Wechsler Adult Intelligence Scale (Um et al. 1992 ). Scores obtained from this abbreviated version of the test show very good correlation with the FullScale Wechsler Adult Intelligence Scale score (Lim et al. 2000; Silverstein 1990 ). There were three to five raters trained to per form the assessment at each center (Seoul, Cheonan, and Ulsan). Interrater reliability was confirmed annually through rater training ses sions and video monitoring of the examination process. All test procedures and interpretation of the results were conducted according to The Standards for Educational and Psychological Testing (American Educational Research Association et al. 1999) .
Prenatal phthalate exposure during pregnancy. Prenatal phthalate exposure was deter mined by measuring phthalate metabolites in the spot urine of the mother during the third trimester of pregnancy (range of gestational age at urine collection: 35.7-41.7 weeks). The spot urine samples were collected at the obstetric clinics between 0900 and 1800 hours. We measured the secondary metabolites of DEHP [mono(2ethyl5hydroxyhexyl) phtha late (MEHHP); mono(2ethyl5oxohexyl) phthalate (MEOHP)] and DBP [monon butyl phthalate (MBP)]. Samples were refrig erated at -20°C. The measurement process used to quantify phthalate metabolites has been described in detail in the Centers for Disease Control and Prevention (CDC) Laboratory Procedure Manual (CDC 2009). The monoester phthalates were measured using highperformance liquid chromatography tan dem mass spectrometry (Agilent 6410 Triple Quad LCMS; Agilent, Santa Clara, CA, USA). One reagent blank and one quality control sample were analyzed simultaneously with each batch of samples. The quality control samples were spiked with pooled urine and a mixture of phthalate monoester standards (100 ng/mL). The betweenday coefficient of variation for the assay ranged from 0.5% to 8.9%. Creatinine concentration was measured using an enzy matic reaction with CREA reagent (Roche, Basel, Switzerland) on a Hitachi 7600 II ana lyzer (Hitachi, Tokyo, Japan). The limits of detection (LODs) of the phthalate metabo lites were 0.056, 0.049, and 0.440 µg/L for MEHHP, MEOHP, and MBP, respectively. The LOD was defined as the concentration of phthalates that could be detected with a signal tonoise ratio of 3 (Boque and Heyden 2009) . Concentrations of phthalate metabolites below the LOD were imputed with a value equal to LOD/2 (Hornung and Reed 1990) .
Statistical analysis. All statistical analyses were performed using SPSS 15.0 for Windows (SPSS, Chicago, IL, USA). Characteristics of the study subjects with respect to maternal phthalate exposure status were analyzed using chisquare tests or ttests. The associations between maternal urine phthalate concentra tion [MEHHP, MEOHP, the molar sum (Wolff et al. 2008) .
Creatininecorrected concentrations of urinary phthalate metabolites (micrograms per gram creatinine) were used to normalize for urine dilution Wolff et al. 2008; Ye et al. 2008) . The model that used natu ral logphthalate biomarkers with the natural logcreatinine in the model produced similar results (data not shown). To select covariates for inclusion in the multivariate models, we searched the literature to identify risk factors associated with phthalate exposure or infant neurodevelopment. The key covariates used in this study were the following: infant sex, birth weight, maternal age at delivery, maternal edu cation level, family income, breastfeeding sta tus, and residential area ). The cova riates were based on selfreported information given during the study interview. The variables were categorical and modeled using catego ries shown in Table 1 . We also examined the inter action between infant sex and phthalate (α = 0.10). For the mothers whose intelli gence was measured, a subgroup analysis was performed to further adjust for maternal intel ligence. For the categorical analysis, quartiles of the phthalate biomarkers were created using the creatininecorrected value.
Results
Participant characteristics. The geographic distribution of MOCEH study participants whose infants were examined at 6 months of age with BSIDII was as follows: Cheonan, n = 178 (24.8%); Seoul, n = 203 (28.3%); and Ulsan, n = 337 (46.9%). From the 718 subjects, we excluded preterm deliveries (birth before 35 weeks, n = 12) and twin births (n = 15) ). Of the resulting 691 mothers, 460 (66.6%) had provided suffi cient urine samples during the third trimester of pregnancy for the analysis of phthalates. Therefore, the data of 460 mother-infant pairs were included in the final analysis. No signifi cant differences were found in the background characteristics between the children included (n = 460) and excluded (n = 231) from the analysis because of lack of urine phthalate exposure information (data not shown), except for maternal age. The mothers of the children included in the analysis (29.9 ± 3.4 years, n = 457) were younger than the mothers of the children not included in the analysis (30.8 ± 3.9 years, n = 227; p = 0.002).
The mean MDI for the total sample (n = 460) was 96.7 (range, 50-133), and the mean PDI was 96.5 (range, 50-134). The mean (± SD) MDI was 96.3 ± 12.2 for male infants and 97.1 ± 11.9 for female infants, and the mean PDI was 94.8 ± 15.0 for male infants and 98.2 ± 15.3 for female infants. The female infants had significantly higher PDI scores than did the male infants (p = 0.02). The PDI scores of the male and female infants at the Ulsan center were significantly differ ent (males = 96.2, females = 101.9, p < 0.01); however, there was no difference between PDI scores of male and female infants at the centers in Cheonan (males = 96.2, females = 97.7, p = 0.9) and Seoul (males = 87.5, females = 90.3, p = 0.4; Table 1) .
Maternal age at delivery, yearly household income, maternal education level, and phthalate biomarkers differed among the regions (Seoul, Cheonan, Ulsan), but birth weight, breast feeding status, gestational age at urine collec tion, and creatinine levels did not (Table 1) .
Prenatal phthalate levels and MDI and PDI. First, we performed a sensitivity analy sis to assess the impact of excluding subjects with dilute urine samples (< 20 mg/dL crea tinine, n = 43). Excluding the dilute urine samples had little impact on point estimates but improved the precision of the analysis (data not shown); consequently, the dilute urine samples were excluded from subsequent analyses. Based on models adjusted for key covariates, MDI was inversely associated with a natural log increase in MEHHP (β = -0.97; 95% CI, -1.85 to -0.08), MEOHP (β = -0.95; 95% CI, -1.87 to -0.03), and HHP + OHP (β = -0.98; 95% CI, -1.90 to -0.06); PDI was inversely associated with the MEHHP (β = -1.20; 95% CI, -2.33 to -0.08) ( Table 2) . Further adjustment for maternal intelligence (based on 227 obser vations with available data) resulted in sig nificant inverse associations of MDI with MEHHP (β = -1.45; 95% CI, -2.72 to -0.17) and MEOHP (β = -1.54; 95% CI, -2.85 to -0.23) and of PDI increase with MEHHP (β = -1.88; 95% CI, -3.40 to -0.36), MEOHP (β = -1.88; 95% CI, -3.44 to -0.32), and MBP (β = -1.07; 95% CI, -2.10 to -0.03) ( Table 2) .
Because phthalates may affect males and females differently, we performed analyses for male and female infants separately. In male infants, MDI was inversely associated with a natural log increase in MEHHP (β = -1.46; 95% CI, -2.70 to -0.22), MEOHP (β = -1.57; 95% CI, -2.87 to -0.28), HHP + OHP (β = -1.57; 95% CI, -2.86 to -0.28), and MBP (β = -0.93; 95% CI, -1.82 to -0.05); PDI was inversely associated with MEHHP (β = -2.36; 95% CI, -3.94 to -0.79), MEOHP (β = -2.05; 95% CI, -3.71 to -0.39), HHP + OHP (β = -2.28; 95% CI, -3.93 to -0.63), and MBP (β = -1.25; 95% CI, -2.40 to -0.11) ( Table 3) . Inverse associations between phthalate biomarkers and developmental indices at 6 months were also observed in females, but the association was weaker and did not reach statistical sig nificance (Table 3 ). The differences between males and females were significant (p < 0.10) for PDI in associations with MEHHP and HHP + OHP only (Table 3) . Table 2 . Association of creatinine-corrected prenatal urinary concentrations of phthalate biomarkers on the infant MDI and the psychomotor index of the BSID-II at 6 months.
All cases (n = 417)
Subgroup with maternal intelligence (n = 227) (Figure 1) . The model was adjusted for infant birth weight, maternal age, maternal education level, family income, breastfeeding status, and residential area. Among female infants, there were no significant differences in MDI or PDI scores among MEHHP quartiles ( Figure 1A) . Differences between males and females were not statistically significant, but among male infants, MDI and PDI scores decreased with increasing MEHHP quartiles, with a significant overall association for PDI (p = 0.01). Male infants in the fourth MEHHP quartile showed lower PDI scores than did those in the first quartile (p = 0.06).
Among female infants, MDI and PDI scores were not significantly different among MEOHP quartiles ( Figure 1B) . Differences between males and females were not statistically significant, but among male infants the MDI and PDI scores decreased with the increase in MEOHP quartiles, with significant differences among quartiles for PDI (p = 0.04).
There were significant group differences in MDI (p = 0.01) and PDI (p < 0.01) scores among MBP quartiles in males ( Figure 1C) , with the lowest scores among those in the third quartile for both outcomes. Among the female infants, there were no significant group differences in MDI or PDI scores among MBP quartiles, although PDI scores tended to decrease. In addition, overall associations between MBP quartiles and the MDI score differed significantly between males and females (p = 0.03).
Discussion
We found an inverse association between pre natal exposure to phthalates and the MDI and PDI scores of infants at 6 months. In this study, we observed a strong inverse association for male infants between all measured phthalate metabolites (MEHHP, MEOHP, and MBP) Figure 1 . Adjusted mean MDI and PDI scores according to quartiles of creatinine-corrected prenatal phthalate metabolite concentrations in maternal urine (based on samples with urine creatinine > 20 mg/dL) adjusted for birth weight, maternal age, maternal education level, family income, breast-feeding status, and residential area. Error bars represent the 95% CIs of the predicted mean. The p-value for the infant sex-phthalate interaction was significant only for MBP and the MDI (p = 0.03). Among the male infants, there were significant group differences in the MDI scores among the MBP quartiles (p = 0.01) and in the PDI scores among the MEHHP (p = 0.06), MEOHP (p = 0.04), and MBP quartiles (p = 0.01). Among the female infants, there were no significant group differences among the phthalate quartiles for either the MDI or the PDI scores. Values for the first, second, third, and fourth quartiles, respectively, were as follows: MEHHP: < 7.6, 7.6 to 15.6, 15.6 to 28.5, and 28.5 to 389.7 µg/gC (micrograms per gram creatinine); MEOHP: < 6.7, 6.7 to 12.8, 12.8 to 23.2, and 23.2 to 471.7 µg/gC; MBP: < 8.4, 8.4 to 26.9, 26.9 to 55.5, and 55.5 to 1157.8 µg/gC. Table 3 . Association of creatinine-corrected prenatal urinary concentrations of phthalate biomarkers on the infant MDI and PDI of the BSID-II at 6 months according to sex. and both developmental indices, whereas none of the associations were significant in female infants. We also observed significant differ ences between males and females in the associa tion between PDI and natural logtransformed MEHHP and the association between MDI and MBP quartiles. These results suggest that infant sex modified associations between phtha lates and developmental scores at 6 months. Sexspecific effects on orientation and motor domains on the Brazelton Neonatal Behavioral Assessment Scale have been reported in neo nates, with male and female infants showing mirror image patterns of each other (Engel et al. 2009 ). Prenatal exposure to phthalates has been associated with reduced masculine play among 3 to 6yearold boys, as measured by the PreSchool Activities Inventory (Swan et al. 2010) . However, no sexspecific differ ences were observed in the association between prenatal phthalate exposure and childhood social impairment at 7-9 years (Miodovnik et al. 2011) . Therefore, followup studies are warranted to determine if differences in neuro developmental effects of phthalates between males and females persist in older children. At 6 months, the BSIDII assesses visual and auditory attention, visual memory, recog nition and imitation of simple sounds, and gross and fine motor skills (Bayley 1993 ). These developmental domains are different from intelligence or executive function, which can be measured only at a later age, making it difficult to compare this study with studies conducted in older children. However, Engel et al. (2010) reported that prenatal exposure to phthalates was associated with externalizing behavior problems (β = 1.24-2.40) on the Behavioral Assessment System for Children Parent Rating Scales and poor executive func tion (β = 1.23) on the Behavioral Rating Inventory of Executive Function at 4-9 years of age. Prenatal exposure to phthalates has also been associated with social impairment on the Social Responsiveness Scale (β = 1.40-1.86) at 7-9 years of age (Miodovnik et al. 2011) . A recent crosssectional study also reported an inverse association between vocabulary subscores on intelligence tests and concur rent urine phthalate levels (β = 0.44-0.53) at 8-11 years of age . The esti mated effect sizes reported for previous studies were slightly lower than or similar to those for PDI (β = 1.20) and MDI (β = 0.95-0.98) in 6monthold infants in our cohort.
Environmental exposure to phthalates in humans may contribute to adverse neu rodevelopmental outcomes in several ways. Phthalates may interfere with the thyroid hor mone system (Ghisari and BonefeldJorgensen 2009; Huang et al. 2007) or the lipid signal transduction pathways that may influence the development of cognitive function (Xu et al. 2007) . Phthalates have been shown to cause hyperactivity in rats, possibly through effects on the dopamine system (Ishido et al. 2004a (Ishido et al. , 2004b . Phthalates have been shown to decrease the number of midbrain dopaminer gic neurons, tyrosine hydroxylase biosynthetic activity (Tanida et al. 2009 ), and tyrosine hydroxylase immunoreactivity (Ishido et al. 2004b) . Phthalates also exhibit antiandrogenic activity (Borch et al. 2006) , which may inter fere with the regulation of normal fetal brain development (Colborn 2004) . However, there is still limited knowledge about the etiological mechanism underlying the possible detrimen tal effects of phthalates on the development of human brain.
The phthalate exposures in this study were generally of the same magnitude as those reported by other studies of pregnant women. Median MEHHP (10.1 µg/L), MEOHP (7.9 µg/L), and MBP (16.6 µg/L) concentra tions in this study were somewhat lower than the median levels in pregnant women in the Children's Environmental Health study (20.0, 17.0, and 36.0 µg/L, respectively) (Wolff et al. 2008) . Geometric mean concentrations of MEHHP (8.9 µg/L), MEOHP (7.4 µg/L), and MBP (12.4 µg/L) in this study were slightly lower than those in pregnant women in the NHANES 2001-2002 study (19.2, 15.6, and 19 .8 µg/L, respectively) (Ye et al. 2009 ). Ethnic and social differences and differ ences in the data collection time points must be taken into account when making compari sons among study populations. Median con centrations of MEHHP, MEOHP, and MBP reported for Korean women > 20 years of age (13.2, 11.2, and 44.8 µg/L, respectively) (Lee et al. 2008 ) and for pregnant Japanese women (10.6, 11.0, and 57.9 µg/L, respectively) (Suzuki et al. 2009 ) were higher than median concentrations in our population of pregnant Korean women.
The limitations of this study need to be considered. First, the possibility that moth ers with large muscle mass and consequently high urinary creatinine concentrations may bear larger babies with higher scores in the development index, resulting in the inverse associations seen in this study, must be con sidered. However, such systemic bias would have resulted in an inverse relationship in both male and female babies. Furthermore, no association was observed between the crea tinine concentration and demographic char acteristics, including the birth weight of the child (data not shown). We have also adjusted for several potential confounders, including maternal intelligence, a wellknown predic tor of neurodevelopment (Mink et al. 2004) . Adjusting for these factors generally strength ened associations between exposure to phtha lates and developmental scores.
Although the spot urine sample in this study was collected between 0900 and 1800 hours, the exact time of the day was unavailable, making it difficult to assess the effect of time of urine collection on phtha late concentration. There have been concerns raised over whether single spot urine tests truly represent the longterm prenatal expo sure to phthalates because of the short half lives of phthalates and the episodic nature of the exposure. However, a recent study showed that the phthalates detected in the spot urine of pregnant women at 25-40 weeks of gesta tion reasonably reflected exposure for approxi mately 2 months (Suzuki et al. 2009 ).
Finally, we measured only three phtha late metabolites: two metabolites of DEHP (MEHHP and MEOHP) and one metabolite of DBP (MBP). Previous studies have shown that the metabolites of DEHP and DBP are associated with thyroid dysfunction in preg nant women (Huang et al. 2007 ), but these compounds continue to be widely used in wall coverings, car interiors, clothing, and toys (Bornehag et al. 2005) . The three metab olites were chosen after careful consideration of exposure amounts, sample availability, and the results of previous studies Engel et al. 2009; ). However, additional studies using multiple prospective measurements and larger sample sizes are needed to expand the interpretation of our results to other phthalates.
In this study, we hypothesized that pre natal exposure to DEHP and DBP would be inversely associated with MDI and PDI as measured by the BSIDII. This study observed a strong inverse association between prenatal exposure to MEHHP, MEOHP, and MBP in the third trimester of pregnancy and the MDI and PDI of the male infants at 6 months. These findings add further support to the pos sibility that prenatal phthalate exposure may be detrimental to neurodevelopment and sug gest possible sex differences in the sensitivity to phthalates.
